SOUTH SAN FRANCISCO, Calif.,
April 30, 2015 /PRNewswire/
-- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today
announced that it will report its first quarter 2015 financial
results after market close on Thursday, May
7, 2015. Rigel senior management will follow the
announcement with a live conference call and webcast at
4:30pm Eastern Time (1:30pm Pacific Time) to discuss the financial
results and provide an update on the Company's clinical programs
and pipeline.
Participants can access the live conference call by dialing
1-855-892-1489 (domestic) or 1-720- 634-2939 (international) and
using the Conference ID number 39677401. The conference call
will also be webcast live and can be accessed from Rigel's website
at www.rigel.com. The webcast will be archived and
available for replay for 30 days after the call via the Rigel
website.
About Rigel
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development
company that discovers and develops novel, small-molecule drugs for
the treatment of inflammatory and autoimmune diseases, cancers, and
muscle disorders. Rigel's pioneering research focuses on signaling
pathways that are critical to disease mechanisms. Rigel currently
has the following product candidates in development: fostamatinib,
an oral spleen tyrosine kinase (SYK) inhibitor, which is in Phase 3
clinical trials for ITP and initiating a Phase 2 clinical trial for
IgAN; R348, an ophthalmic JAK/SYK inhibitor, in a Phase 2 clinical
trial for dry eye in ocular graft-versus-host disease (GvHD); two
oncology product candidates in Phase 1 development with partners
BerGenBio AG and Daiichi Sankyo; and two preclinical programs with
partners AstraZeneca, for R256 in asthma, and Bristol-Myers Squibb,
for TGF beta inhibitors in immuno-oncology.
Contact: Ryan D. Maynard
Phone: 650.624.1284
Email: invrel@rigel.com
Media Contact: Susan C. Rogers,
Rivily, Inc.
Phone: 650.430.3777
Email: susan@rivily.com
Logo -
http://photos.prnewswire.com/prnh/20030226/RIGLLOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/rigel-announces-conference-call-and-webcast-to-report-first-quarter-2015-financial-results-and-pipeline-update-300074811.html
SOURCE Rigel Pharmaceuticals, Inc.